Company Overview and News

 
Gateway Distriparks pays ₹250 crore to buy partial stake in subsidiary

2018-10-05 thehindubusinessline
Gateway Distriparks (GDL) has paid a total of ₹250 crore to acquire a partial stake in its subsidiary Gateway Rail Freight (GRFL) held by PE firm Blackstone, while the logistics firm will pay ₹560 crore by December 28 for the remaining stake.
GDL 532622

 
Gateway Distriparks pays ₹250 crore to buy partial stake in subsidiary

2018-10-05 thehindubusinessline
Gateway Distriparks (GDL) has paid a total of ₹250 crore to acquire a partial stake in its subsidiary Gateway Rail Freight (GRFL) held by PE firm Blackstone, while the logistics firm will pay ₹560 crore by December 28 for the remaining stake.
GDL 532622

 
Gateway Distriparks Limited - Updates

2018-10-05 nseindia
The information displayed herein is uploaded by the concerned Company. The said uploaded information is displayed without any verification of adequacy, accuracy and veracity. The Exchange in discharge of its role of dissemination of uploaded information on this website immediately on its receipt. The Company shall be solely responsible and liable for any omission, commission, errors and misrepresentations in the contents of the Information.
GDL 532622

 
Gateway Distriparks Limited - Updates

2018-10-01 nseindia
The information displayed herein is uploaded by the concerned Company. The said uploaded information is displayed without any verification of adequacy, accuracy and veracity. The Exchange in discharge of its role of dissemination of uploaded information on this website immediately on its receipt. The Company shall be solely responsible and liable for any omission, commission, errors and misrepresentations in the contents of the Information.
GDL 532622

 
Gateway Distriparks Limited - Updates

2018-09-11 nseindia
The information displayed herein is uploaded by the concerned Company. The said uploaded information is displayed without any verification of adequacy, accuracy and veracity. The Exchange in discharge of its role of dissemination of uploaded information on this website immediately on its receipt. The Company shall be solely responsible and liable for any omission, commission, errors and misrepresentations in the contents of the Information.
GDL 532622

 
Gateway Distriparks Limited - Outcome of Board Meeting

2018-08-06 nseindia
The information displayed herein is uploaded by the concerned Company. The said uploaded information is displayed without any verification of adequacy, accuracy and veracity. The Exchange in discharge of its role of dissemination of uploaded information on this website immediately on its receipt. The Company shall be solely responsible and liable for any omission, commission, errors and misrepresentations in the contents of the Information.
GDL 532622

 
Gateway Distriparks Limited - Analysts/Institutional Investor Meet/Con. Call Updates

2018-08-04 nseindia
The information displayed herein is uploaded by the concerned Company. The said uploaded information is displayed without any verification of adequacy, accuracy and veracity. The Exchange in discharge of its role of dissemination of uploaded information on this website immediately on its receipt. The Company shall be solely responsible and liable for any omission, commission, errors and misrepresentations in the contents of the Information.
GDL 532622

 
Gateway Distriparks rises 8% as profit doubles in June quarter

2018-08-01 moneycontrol
Shares of Gateway Distriparks rose 8 percent intraday Wednesday as company reported strong numbers in the quarter ended June 2018.
GDL 532622

 
Gateway Distriparks Limited - Press Release

2018-08-01 nseindia
The information displayed herein is uploaded by the concerned Company. The said uploaded information is displayed without any verification of adequacy, accuracy and veracity. The Exchange in discharge of its role of dissemination of uploaded information on this website immediately on its receipt. The Company shall be solely responsible and liable for any omission, commission, errors and misrepresentations in the contents of the Information.
GDL 532622

 
Gateway Distriparks Limited - Outcome of Board Meeting

2018-08-01 nseindia
The information displayed herein is uploaded by the concerned Company. The said uploaded information is displayed without any verification of adequacy, accuracy and veracity. The Exchange in discharge of its role of dissemination of uploaded information on this website immediately on its receipt. The Company shall be solely responsible and liable for any omission, commission, errors and misrepresentations in the contents of the Information.
GDL 532622

 
Gateway Distriparks Limited - Financial Result Updates

2018-08-01 nseindia
The information displayed herein is uploaded by the concerned Company. The said uploaded information is displayed without any verification of adequacy, accuracy and veracity. The Exchange in discharge of its role of dissemination of uploaded information on this website immediately on its receipt. The Company shall be solely responsible and liable for any omission, commission, errors and misrepresentations in the contents of the Information.
GDL 532622

 
Gateway Distriparks Limited - Shareholders meeting

2018-07-31 nseindia
The information displayed herein is uploaded by the concerned Company. The said uploaded information is displayed without any verification of adequacy, accuracy and veracity. The Exchange in discharge of its role of dissemination of uploaded information on this website immediately on its receipt. The Company shall be solely responsible and liable for any omission, commission, errors and misrepresentations in the contents of the Information.
GDL 532622

 
Tata Global, RInfra, Jindal Saw results

2018-07-31 thehindubusinessline
AB Fashion, Apollo Tyres, Astec Lifesciences, Ballarpur Industries, Exide India, Elecon Engineering, Emami, FDC, Gateway Distriparks, HFCL, HEG, Indoco Remedies, Jayshree Tea, Jindal Saw, Navneet Education, Orient Paper, Pidilite Industries, Poly Medicure, RInfra, Repro India, Tata Global, Thangamayil, Torrent Power, TCI Developers, V2 Retail, Zuari Agro, and Zuari Global are among the 51 firms that will declare their April-June quarter results on Wednesday.
533393 REPRO NAVNETEDUL 531768 532779 TCIDEVELOP 532612 532215 PIDILITIND ZUARIGLOB PDLTY AXISBANK TORNTPOWER 500378 505700 500331 ELECON V2RETAIL AXB KMBKY 500877 INDOCO APOLLOTYRE 532867 ASTEC AYRQY 532622 532687 AXBKY 533138 AXBA ONP 508989 GDL JINDALSAW KOTAKBANK 500102 500247 BALLARPUR 500780 POLYMED

 
Gateway Distriparks Limited - Trading Window

2018-07-23 nseindia
The information displayed herein is uploaded by the concerned Company. The said uploaded information is displayed without any verification of adequacy, accuracy and veracity. The Exchange in discharge of its role of dissemination of uploaded information on this website immediately on its receipt. The Company shall be solely responsible and liable for any omission, commission, errors and misrepresentations in the contents of the Information.
GDL 532622

Related Articles

ALIM: Alimera Sciences Analysis and Research Report

2018-10-01 - Asif

Overview The following discussion and analysis should be read in conjunction with its unaudited interim condensed consolidated financial statements and the related notes that appear elsewhere in this quarterly report on Form 10-Q. This discussion contains forward-looking statements reflecting its current expectations that involve risks and uncertainties. Actual results may differ materially from those discussed in these forward-looking statements due to a number of factors, including those set forth in the section entitled “Risk Factors” in its most recent annual report on Form 10-K. For further information regarding forward-looking statements, please refer to the “Special Note Regarding Forward-Looking Statements and Projections” immediately after the index to this quarterly report on Form 10-Q. Alimera Sciences, Inc., and its subsidiaries (we or Alimera), is a pharmaceutical company that specializes in the commercialization and development of prescription ophthalmic pharma...

DMPI: DelMar Pharmaceuticals Analysis and Research Report

2018-09-25 - Asif

Background DelMar Pharmaceuticals, Inc. is a clinical stage drug development company with a focus on the treatment of cancer. The company's mission is to benefit patients and create shareholder value by developing and commercializing anti-cancer therapies for patients whose tumors exhibit features that make them resistant to, or unlikely to respond to, currently available therapies, particularly for orphan cancer indications where patients have failed, or are unlikely to respond to, currently available therapy. DelMar Pharmaceuticals is developing VAL-083, a novel, DNA-targeting agent, for the treatment of glioblastoma multiforme (“GBM”) and potentially other solid tumors, including ovarian cancer. VAL-083 is a first-in-class, DNA-targeting chemotherapeutic that demonstrated activity against a range of tumor types in prior Phase 1 and Phase 2 clinical studies sponsored by the US National Cancer Institute (“NCI”). The company's recent research has highlighted the opportunit...

RIGL: Rigel Pharmaceuticals Analysis and Research Report

2018-09-18 - Asif

Overview Rigel Pharmaceuticals is a biotechnology company dedicated to discovering, developing and providing novel small molecule drugs that significantly improve the lives of patients with immune and hematologic disorders, cancer and rare diseases. The company's pioneering research focuses on signaling pathways that are critical to disease mechanisms. The company's first FDA-approved product is TAVALISSE™ (fostamatinib disodium hexahydrate), an oral spleen tyrosine kinase (SYK) inhibitor, for the treatment of adult patients with chronic immune thrombocytopenia who have had an insufficient response to a previous treatment. The company's current clinical programs include Phase 2 studies of fostamatinib in autoimmune hemolytic anemia and IgA nephropathy, and a Phase 1 study for its IRAK program. In addition, Rigel Pharmaceuticals has product candidates in development with partners BerGenBio AS, Daiichi Sankyo, and Aclaris Therapeutics. Since inception, Rigel Pharmaceuticals h...

Silicon Investor Message Boards

This table lists all message boards related to NSE:GDL / GATEWAY DISTRIPARKS LTD. on message board site Silicon Investor.

Goodfellow GDL on MSE Goodfellow GDL on MSE Goodfellow GDL on MSE